A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of the trial is to test for bioequivalence between
two formulations of insulin degludec/insulin aspart (IDegAsp) to see if the efficacy and
safety obtained with formulation 1 can be assumed identical for formulation 2.